Enveda's $311M Funding: Boosting AI-Driven Drug Development
Enveda Biosciences has raised $311 million to drive AI-based drug development, focusing on nature-derived treatments for skin issues and weight management.
Latest news and articles
2 articles published
Enveda Biosciences has raised $311 million to drive AI-based drug development, focusing on nature-derived treatments for skin issues and weight management.
Researchers are merging AI and quantum computing to transform drug development, targeting rare diseases and underserved populations. This collaboration could change medicine.